• News
  • Contact Us
  • |
  • International
  • United States
  • Canada
Leadiant Biosciences
  • About Leadiant Biosciences
    • Management Team
  • Research and Development
  • Products
  • Diseases
    • CTX
    • ADA-SCID
    • Hodgkin Disease
All Posts By

daniela.perri

Recent Posts

  • EMA grants Marketing Authorization for Chenodeoxycholic Acid Leadiant

Archives

  • June 2017
Leadiant Biosciences
Leadiant Biosciences S.p.A. (Corporate)
via Sudafrica
20 - 00144 Roma
Italia
©2022 Leadiant Biosciences, Ltd. / London, UK
GL-NP-2000002
Date of Production: Feb, 2022
  • About Leadiant Biosciences
    • Management Team
  • Research and Development
  • Products
  • Diseases
    • CTX
    • ADA-SCID
    • Hodgkin Disease
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Modern Slavery Act Statement (PDF)
  • Leadiant Biosciences, Inc. (U.S. and Canada)
  • About Leadiant Biosciences
    • Management Team
  • Research and Development
  • Products
  • Diseases
    • CTX
    • ADA-SCID
    • Hodgkin Disease
  • News
  • Contact Us
  • |
  • International
  • United States
  • Canada
  • About Leadiant Biosciences
    • Management Team
    • Back
  • Research and Development
  • Products
  • Diseases
    • CTX
    • ADA-SCID
    • Hodgkin Disease
    • Back
  • Contact Us
  • United States
  • Canada

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences Inc. Canada website. The information is intended for Canadian audiences only.

Continue Cancel

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences Inc. U.S. website. The information is intended only for residents of the United States.

Continue Cancel

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences S.p.A. (Corporate) website.

Continue Cancel